Literature DB >> 12451384

Epidermolysis bullosa acquisita and multiple myeloma.

Leela Engineer1, Edward C Dow, Irwin M Braverman, A Razzaque Ahmed.   

Abstract

The coexistence in the same patient of epidermolysis bullosa acquisita (a rare, autoimmune, acquired mucocutaneous blistering disorder) and multiple myeloma (a plasma cell neoplasm) is extremely uncommon. We describe a patient in whom both of these diseases occurred simultaneously. Intravenous immunoglobulins were used to treat both diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451384     DOI: 10.1067/mjd.2002.113682

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  IgA pemphigus associated with monoclonal gammopathy completely resolved after achievement of complete remission of multiple myeloma with bortezomib, cyclophosphamide and dexamethasone regimen.

Authors:  Zdenek Adam; Marta Krejcí; Ludek Pour; Josef Feit; Tomás Büchler; Roman Hájek
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

Review 2.  High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.

Authors:  Norito Ishii; Takashi Hashimoto; Detlef Zillikens; Ralf J Ludwig
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 3.  Epidermolysis Bullosa Acquisita: The 2019 Update.

Authors:  Hiroshi Koga; Catherine Prost-Squarcioni; Hiroaki Iwata; Marcel F Jonkman; Ralf J Ludwig; Katja Bieber
Journal:  Front Med (Lausanne)       Date:  2019-01-10

Review 4.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.